Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03093597 · ClinicalTrials.gov registry record · NA
Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin
A NA study, sponsored by University of Arizona.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT03093597: Completed NA study, sponsored by University of Arizona.
NCT03093597 is a NA study that has completed, run by University of Arizona. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03093597, a NA study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of the study is to compare the changes in the appearance of dry skin after the use various moisturizers: white petrolatum ointment, coconut oil, jojoba oil, and almond oil in patients with dry skin.
Primary Outcome
The clinical severity of xerosis of the 4 location will be graded by a trained observed using a previously validated Dry Skin Scale and by analysis of the digital photos.
Interventions
- OTHER virgin coconut oil
- OTHER virgin jojoba oil
- OTHER virgin almond oil
- OTHER white petrolatum ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-03-27 |
| Est. Completion | 2017-12-12 |
| Phase | NA |
What the finished NCT03093597 record still lists
NCT03093597 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which virgin coconut oil is the first listed.
NCT03093597 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03093597 about?
NCT03093597 is a clinical study titled "Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer in Dry Skin". The purpose of the study is to compare the changes in the appearance of dry skin after the use various moisturizers: white petrolatum ointment, coconut oil, jojoba oil, and almond oil in patients with dry skin.
What is the current status of trial NCT03093597?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-03-27. Estimated completion is 2017-12-12.
What interventions are being tested in trial NCT03093597?
The interventions under investigation include: virgin coconut oil (OTHER), virgin jojoba oil (OTHER), virgin almond oil (OTHER), white petrolatum ointment (OTHER).
Who is sponsoring clinical trial NCT03093597?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03093597's enrollment target sits among peer trials
37 1540th of 2000 higher than 460 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI